| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $46.0M | -17.8% |
| Cost of Revenue | $43.3M | -16.8% |
| Gross Profit | $2.7M | -31.3% |
| R&D Expense | $8.0M | -24.7% |
| SG&A Expense | $24.8M | -29.3% |
| Operating Income | -$33.1M | +27.9% |
| Pre-tax Income | -$25.3M | +49.5% |
| Income Tax | $23K | -37.8% |
| Net Income | -$25.3M | +49.5% |
| EPS (Basic) | -$2.71 | +59.5% |
| EPS (Diluted) | -$2.71 | +59.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.0M | +27.7% |
| Accounts Receivable | $6.0M | -77.5% |
| Inventory | $25.0M | -31.7% |
| Current Assets | $49.9M | -39.4% |
| Total Assets | $60.4M | -38.6% |
| Current Liabilities | $23.7M | -49.3% |
| Total Liabilities | $37.1M | -42.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.4M | +111.0% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $61K | -99.9% |
| Financing Cash Flow | -$2.4M | +21.3% |
| Free Cash Flow | $5.4M | +110.9% |
| $23.3M |
| -30.7% |